DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 6Dr. Reddy's Laboratories
02 1Olpha
03 3NanoAlvand
04 2Aizant Drug Research Solutions Pvt. Ltd.
05 2Aurobindo Pharma Limited
06 3Bluepharma
07 3MSN Laboratories
08 1NANO DARU
09 3Pfizer Consumer Healthcare
10 21Pfizer Inc
11 3Pharmascience Inc.
12 3Pluviaendo
13 3Sun Pharmaceutical Industries Limited
14 3Synthon Pharmaceuticals
15 3Taro Pharmaceutical Industries
16 3Tecnimede
17 1TherDose Pharma
18 3XYZ Pharma
01 3CAP
02 3CAPSULE; ORAL
03 13CAPSULE;ORAL
04 3Caps
05 10Capsule
06 3Capsule, hard
07 3Filmtabl
08 3Hard Capsules
09 3Hard Gelatin Capsule
10 3Oral Solid Dosage Form
11 9TABLET
12 6TABLET;ORAL
13 1Tablet
14 1Tablets
15 3Blank
01 3DISCN
02 1Dossier Readiness: Q3 2025
03 3Lead Market Dossiers- Filed
04 3Lead Market Dossiers- Tentative\nApproved in US
05 3Originator
06 6RX
07 48Blank
01 3Cybrin
02 9IBRANCE
03 12Ibrance
04 16PALBOCICLIB
05 3PMS-PALBOCICLIB
06 1Palbociclib Pfizer 100 mg
07 1Palbociclib Pfizer 125 mg
08 1Palbociclib Pfizer 75 mg
09 3TARO-PALBOCICLIB
10 18Blank
01 3Australia
02 9Canada
03 7India
04 4Iran
05 1Latvia
06 3Norway
07 6Portugal
08 3South Africa
09 6Switzerland
10 3Turkey
11 22USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness: Q3 2025
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness: Q3 2025
Registration Country : Latvia
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Cybrin
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Cybrin
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Cybrin
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 213152
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number : 213152
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 213086
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number : 213086
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number : 214758
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 214758
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number : 214758
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 75MG
Packaging :
Approval Date : 2015-02-03
Application Number : 207103
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2015-02-03
Application Number : 207103
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2015-02-03
Application Number : 207103
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : TABLET;ORAL
Dosage Strength : 75MG
Packaging :
Approval Date : 2019-11-01
Application Number : 212436
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2019-11-01
Application Number : 212436
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : TABLET;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2019-11-01
Application Number : 212436
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE; ORAL
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number : 213107
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE; ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 213107
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE; ORAL
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number : 213107
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : TABLET;ORAL
Dosage Strength : 75MG
Packaging :
Approval Date : 2024-06-05
Application Number : 215570
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number : 213091
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 213091
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number : 213091
Regulatory Info :
Registration Country : USA
